|
WO2020170254A1
|
|
Treatment of diseases with multimeric peptides
|
|
WO2020165901A1
|
|
Site specific recombinase integrase variants and uses thereof in gene editing in eukaryotic cells
|
|
WO2020136657A1
|
|
Polymeric nanovaccines and uses thereof
|
|
WO2020121313A1
|
|
Integrated drug discovery platform for inborn error of metabolism disorders
|
|
WO2018015881A1
|
|
Modular platform for targeted therapeutics
|
|
WO2017221256A1
|
|
Ossicular replacement prosthesis
|
|
US2018018709A1
|
|
Information spread in social networks through scheduling seeding methods
|
|
WO2017191627A1
|
|
Antibodies to interleukin 13 receptor alpha-1 (il-13r alpha 1) and uses thereof
|
|
WO2017145165A1
|
|
Compositions and methods for diagnosis and treatment of central nervous system metastases
|
|
WO2017163230A1
|
|
Method and system for converting an image to text
|
|
US2017316552A1
|
|
Blind image deblurring via progressive removal of blur residual
|
|
WO2017138006A1
|
|
Magnetic field sensing systems and methods
|
|
WO2017137994A1
|
|
Particle manipulation system (pms)
|
|
WO2017137977A1
|
|
Modulator using a micro-ring resonator
|
|
WO2017134664A1
|
|
Fungal endophyte species
|
|
WO2017130190A1
|
|
Novel formulation of neuroprotective peptides
|
|
IL249977D0
|
|
Three-dimensional tumor models, methods of fabricating same and uses thereof
|
|
WO2017103930A1
|
|
Particles comprising decellularized omentum
|
|
WO2017098517A1
|
|
Method and system for sensing by modified nanostructure
|
|
US2017154163A1
|
|
Clinically relevant synthetic lethality based method and system for cancer prognosis and therapy
|
